CANNABIS POLAND AB ZY-10 (8TE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.304x

Based on the latest financial reports, CANNABIS POLAND AB ZY-10 (8TE) has a cash flow conversion efficiency ratio of -0.304x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-463.42K ≈ $-541.78K USD) by net assets (€1.52 Million ≈ $1.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CANNABIS POLAND AB ZY-10 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how CANNABIS POLAND AB ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 8TE total liabilities for a breakdown of total debt and financial obligations.

CANNABIS POLAND AB ZY-10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CANNABIS POLAND AB ZY-10 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Northcliff Citranusa Indonesia Tbk PT
JK:SKYB
-0.062x
Canada Carbon Inc.
V:CCB
0.000x
Colibri Resource Corp
V:CBI
-0.043x
Portofino Resources Inc
V:POR
-0.013x
Warpaint London PLC
LSE:W7L
0.065x
KATORO GOLD PLC LS-01
F:622
N/A
Heads UP Ventures Limited
NSE:HEADSUP
0.002x
Fram Skandinavien AB Series B
ST:FRAM-B
-3.021x

Annual Cash Flow Conversion Efficiency for CANNABIS POLAND AB ZY-10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of CANNABIS POLAND AB ZY-10 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see CANNABIS POLAND AB ZY-10 market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.52 Million
≈ $1.78 Million
€-2.17 Million
≈ $-2.54 Million
-1.426x -138.71%
2024-12-31 €3.54 Million
≈ $4.14 Million
€-2.11 Million
≈ $-2.47 Million
-0.598x +37.85%
2023-12-31 €1.36 Million
≈ $1.58 Million
€-1.30 Million
≈ $-1.52 Million
-0.961x +13.37%
2022-12-31 €321.96K
≈ $376.41K
€-357.28K
≈ $-417.70K
-1.110x +42.68%
2021-12-31 €480.84K
≈ $562.15K
€-930.97K
≈ $-1.09 Million
-1.936x --

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic
Market Cap
$1.75 Million
€1.50 Million EUR
Market Cap Rank
#29822 Global
#2614 in Germany
Share Price
€0.03
Change (1 day)
+0.00%
52-Week Range
€0.02 - €0.10
All Time High
€0.69
About

Cannabis Poland S.A. operates in the medical cannabis industry in Poland. The company distributes and sells cannabidiol (CBD) oils and herbs, inhalers, and vaporizers, as well as dietary supplements and cosmetics for humans and animals. It sells its products through HempWish.pl and Vapem.eu online stores. The company also engages in the research and development of CBD-based drugs based on scienti… Read more